Annual Working Capital
$20.22 M
-$14.68 M-42.06%
December 31, 2022
Summary
- As of February 10, 2025, DFFN annual working capital is $20.22 million, with the most recent change of -$14.68 million (-42.06%) on December 31, 2022.
- During the last 3 years, DFFN annual working capital has risen by +$7.29 million (+56.38%).
Performance
DFFN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$14.23 M
-$2.05 M-12.59%
June 30, 2023
Summary
- As of February 10, 2025, DFFN quarterly working capital is $14.23 million, with the most recent change of -$2.05 million (-12.59%) on June 30, 2023.
- Over the past year, DFFN quarterly working capital has dropped by -$12.44 million (-46.64%).
Performance
DFFN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DFFN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.1% | -46.6% |
| 3 y3 years | +56.4% | -42.9% |
| 5 y5 years | +189.8% | +9.3% |
DFFN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.1% | at low | -59.2% | at low |
| 5 y | 5-year | -42.1% | -36.1% | -68.5% | -26.7% |
| alltime | all time | -42.1% | -200.9% | -68.5% | -317.6% |
Diffusion Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $14.23 M(-12.6%) |
| Mar 2023 | - | $16.28 M(-19.5%) |
| Dec 2022 | $20.22 M(-42.1%) | $20.22 M(-15.9%) |
| Sep 2022 | - | $24.05 M(-9.8%) |
| Jun 2022 | - | $26.67 M(-12.9%) |
| Mar 2022 | - | $30.62 M(-12.3%) |
| Dec 2021 | $34.90 M(+113.6%) | $34.90 M(-8.1%) |
| Sep 2021 | - | $37.97 M(-9.1%) |
| Jun 2021 | - | $41.76 M(-7.6%) |
| Mar 2021 | - | $45.20 M(+176.6%) |
| Dec 2020 | $16.34 M(+26.4%) | $16.34 M(-18.3%) |
| Sep 2020 | - | $19.99 M(-19.8%) |
| Jun 2020 | - | $24.93 M(+139.0%) |
| Mar 2020 | - | $10.43 M(-19.3%) |
| Dec 2019 | $12.93 M(+59.4%) | $12.93 M(+135.1%) |
| Sep 2019 | - | $5.50 M(-34.3%) |
| Jun 2019 | - | $8.37 M(+61.2%) |
| Mar 2019 | - | $5.19 M(-36.0%) |
| Dec 2018 | $8.11 M(+16.3%) | $8.11 M(-23.7%) |
| Sep 2018 | - | $10.62 M(-18.4%) |
| Jun 2018 | - | $13.02 M(-16.9%) |
| Mar 2018 | - | $15.67 M(+124.6%) |
| Dec 2017 | $6.98 M(-346.1%) | $6.98 M(-208.1%) |
| Sep 2017 | - | -$6.45 M(-45.1%) |
| Jun 2017 | - | -$11.76 M(-62.0%) |
| Mar 2017 | - | -$30.97 M(+992.4%) |
| Dec 2016 | -$2.83 M(-595.8%) | -$2.83 M(+618.0%) |
| Sep 2016 | - | -$394.80 K(-126.5%) |
| Jun 2016 | - | $1.49 M(-63.2%) |
| Mar 2016 | - | $4.04 M(+607.1%) |
| Dec 2015 | $571.80 K(-97.4%) | $571.80 K(-95.8%) |
| Sep 2015 | - | $13.60 M(-10.9%) |
| Jun 2015 | - | $15.26 M(-19.3%) |
| Mar 2015 | - | $18.91 M(-13.4%) |
| Dec 2014 | $21.83 M | $21.83 M(-5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $23.03 M(-9.0%) |
| Jun 2014 | - | $25.31 M(-415.7%) |
| Mar 2014 | - | -$8.02 M(+36.3%) |
| Dec 2013 | -$5.88 M(-71.2%) | -$5.88 M(-7.6%) |
| Sep 2013 | - | -$6.36 M(-26.1%) |
| Jun 2013 | - | -$8.60 M(-60.4%) |
| Mar 2013 | - | -$21.71 M(+6.5%) |
| Dec 2012 | -$20.39 M(+4.6%) | -$20.39 M(+120.5%) |
| Sep 2012 | - | -$9.25 M(+8.5%) |
| Jun 2012 | - | -$8.52 M(+50.3%) |
| Mar 2012 | - | -$5.67 M(-70.9%) |
| Dec 2011 | -$19.49 M(+351.4%) | -$19.49 M(<-9900.0%) |
| Sep 2011 | - | $187.30 K(-95.1%) |
| Jun 2011 | - | $3.78 M(-175.6%) |
| Mar 2011 | - | -$5.01 M(+16.0%) |
| Dec 2010 | -$4.32 M(+36.6%) | -$4.32 M(+36.5%) |
| Sep 2010 | - | -$3.16 M(+10.4%) |
| Jun 2010 | - | -$2.86 M(-3.4%) |
| Mar 2010 | - | -$2.96 M(-6.2%) |
| Dec 2009 | -$3.16 M(-22.5%) | -$3.16 M(-28.8%) |
| Sep 2009 | - | -$4.44 M(+10.6%) |
| Jun 2009 | - | -$4.02 M(+4.1%) |
| Mar 2009 | - | -$3.86 M(-5.4%) |
| Dec 2008 | -$4.08 M(-36.5%) | -$4.08 M(-36.4%) |
| Sep 2008 | - | -$6.41 M(+2.7%) |
| Jun 2008 | - | -$6.24 M(+4.8%) |
| Mar 2008 | - | -$5.96 M(-7.2%) |
| Dec 2007 | -$6.42 M(+4390.3%) | -$6.42 M(+3052.3%) |
| Sep 2007 | - | -$203.70 K(+6.6%) |
| Jun 2007 | - | -$191.00 K(+28.9%) |
| Mar 2007 | - | -$148.20 K(+3.6%) |
| Dec 2006 | -$143.00 K(+50.7%) | -$143.00 K |
| Dec 2005 | -$94.90 K(-102.9%) | - |
| Dec 1999 | $3.30 M(-73.6%) | - |
| Dec 1998 | $12.50 M | - |
FAQ
- What is Diffusion Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals annual working capital year-on-year change?
- What is Diffusion Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Diffusion Pharmaceuticals?
- What is Diffusion Pharmaceuticals quarterly working capital year-on-year change?
What is Diffusion Pharmaceuticals annual working capital?
The current annual working capital of DFFN is $20.22 M
What is the all time high annual working capital for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high annual working capital is $34.90 M
What is Diffusion Pharmaceuticals annual working capital year-on-year change?
Over the past year, DFFN annual working capital has changed by -$14.68 M (-42.06%)
What is Diffusion Pharmaceuticals quarterly working capital?
The current quarterly working capital of DFFN is $14.23 M
What is the all time high quarterly working capital for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals all-time high quarterly working capital is $45.20 M
What is Diffusion Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, DFFN quarterly working capital has changed by -$12.44 M (-46.64%)